Current Perspectives in the Treatment of Ovarian Cancer: An Update on the Role of Topotecan

Current Perspectives in the Treatment of Ovarian Cancer: An Update on the Role of Topotecan Guest Editors: Deborah K. Armstrong Oncologist 2002; 7(Suppl 5): 1-55 Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in clinical pharmacology and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). The National Institutes of Health/Foundation for Advanced Education in the Sciences(NIH/FAES) designates this educational activity for 1 category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

• Emerging Role of Topotecan in Front-Line Treatment of Carcinoma of the Ovary EXPIRED
• Update on the Treatment of Cervical and Uterine Carcinoma: Focus on Topotecan EXPIRED
• Alternate Dosing Schedules for Topotecan in the Treatment of Recurrent Ovarian Cancer EXPIRED
• Relapsed Ovarian Cancer: Challenges and Management Strategies for a Chronic Disease EXPIRED
• Management of Treatment-Related Toxicity in Advanced Ovarian Cancer EXPIRED
• Update on the Role of Topotecan in the Treatment of Recurrent Ovarian Cancer EXPIRED